About
Looking for more information?
Contact our responsive and friendly client services team any time.
INVESTOR PRESENTATION - MGC PHARMACEUTICALS LTD
MGC PHARMACEUTICALS LTD
Health Care
MGC Pharmaceuticals Limited (ASX:MXC, also listed on US OTCQB) is a European biopharma company supplying GMP Phytocannabinoid derived medicines to patients globally, with a core strategy of "Seed to Pharma" implementation. The company has operations spanning Europe and Australia.
Read moreMarket Cap
34.46m
Price at Close
$0.021
4w avg. Volume
3.33m
4w avg. Turnover
$76.64k
Announcements
| announcement | t+2 movement | date |
|---|---|---|
| - | 28 Oct 2020 |
| -4.55% | 27 Oct 2020 |
| 0.00% | 26 Oct 2020 |
| 0.00% | 26 Oct 2020 |
| +4.35% | 19 Oct 2020 |
| -4.17% | 14 Oct 2020 |
| +4.35% | 11 Oct 2020 |
| +4.55% | 06 Oct 2020 |
| -4.35% | 02 Oct 2020 |
| -4.35% | 02 Oct 2020 |
Market Data
Current Price
$0.021
52WK HIGH
$0.042
52WK LOW
$0.015
1YR RETURN
-38.24%
1YR RETURN VS. SECTOR
-53.80%
90 DAY RETURN
0.00%
ASX RANK
1,225
/2,011
SECTOR RANK
21
/30
SHARES OUTSTANDING
1.64b
MGC PHARMACEUTICALS LTD
Health Care
MGC Pharmaceuticals Limited (ASX:MXC, also listed on US OTCQB) is a European biopharma company supplying GMP Phytocannabinoid derived medicines to patients globally, with a core strategy of "Seed to Pharma" implementation. The company has operations spanning Europe and Australia.
Read moreMarket Cap
34.46m
Price at Close
$0.021
4w avg. Volume
3.33m
4w avg. Turnover
$76.64k
ASX:MXC is not raising right now
Want to invest?
Contact Us
(03) 9028 2888
clients@freshequities.com
Address
Level 7, 388 Bourke St
Melbourne VIC 3000
Australia